查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197048

黃金納米顆粒市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Gold Nanoparticles Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，全球金納米粒子市場預計將以超過 10% 的複合年增長率增長。

COVID-19 對最近調查的市場產生了負面影響。 電子行業是金納米粒子的主要消費者，受到疫情的嚴重影響。 與 2019 年相比，2020 年全球電子產品出貨量下降了 337 萬台。 由於限制和封鎖，許多進出口已暫停一段時間。 由於旅行限制和社會疏遠協議，更多的項目和工廠被暫停。 隨著市場開放和大多數國家的封鎖解除，未來幾年對於金納米粒子市場來說將是一個令人鼓舞的跡象。

主要亮點

  • 從中期來看，納米技術在醫療行業應用的擴展和高端電子行業需求的增加是推動市場發展的主要因素。
  • 另一方面，金價波動預計會阻礙市場增長。
  • 在預測期內，電子行業的技術創新可能會為市場帶來機遇。
  • 預計北美地區將主導全球納米粒子市場，預計北美地區在整個預測期內增長最快。

金納米粒子市場趨勢

靶向給藥主導市場

  • 靶向給藥領域是金納米粒子市場最大的應用基礎之一。
  • 靶向藥物遞送系統是指通過納米顆粒將藥物或藥理活性劑□□選擇性地遞送至精確的相應作用或吸收位點，而不是遞送至非靶器官、組織或細胞的藥物。它是一種先進的形式輸送系統。
  • 將納米粒子引入靶向藥物遞送系統帶來了各種優勢，包括高治療效果、高靶向效率和可重複性。
  • 金納米粒子用於將多種藥物分子、疫苗、重組蛋白或核甘酸遞送至目標，控制通過生物刺激（內部）或光激活（外部）釋放的藥物量。這也是可能的。
  • 2019 年，美國的醫療保健支出從 2018 年的 4838 億美元增長近 4% 至約 5110 億美元。 人口老齡化和個人健康風險的增加預計只會推動靶向藥物輸送，從而推動該領域的金納米顆粒市場。
  • 金納米粒子的其他應用之一是可以使用一些特殊聚合物（例如聚乙二醇 (PEG)）對其表面進行修飾。 這有望提高金納米粒子在不同生理條件下的穩定性，並實現金納米粒子的不同組合。 預計這將進一步增加金納米粒子在藥物輸送應用中的使用。
  • 因此，預計上述所有因素都將在未來幾年推動所研究市場的需求。

北美主導市場

  • 在預測期內，預計北美地區將主導全球金納米粒子市場。
  • 美國的醫療技術是該地區最重要和最具活力的行業之一，並且繼續成為推動醫療保健系統變革的推動力。
  • 美國是世界領先的醫療保健行業之一，美國醫療保健支出佔該國 GDP 的 17%，2019 年達到 3.8 萬億美元，較 2018 年同比增長。增長 4.6%。 預計這種增長將在未來幾年繼續。
  • 該國的醫療技術在世界上名列前茅，並提供尖端的救生和維持生命的產品。 在大量研發投資的推動下，該國的醫療技術在所有相關指標上都樹立了標準，包括增長、就業趨勢、產出、出口、全球市場份額和風險資本融資。
  • 通常，大約 35% 到 40% 的國內醫療器械產量用於出口，而美國國內消費量中有類似比例是進口的。 國際銷售額，包括來自海外子公司的銷售額，約占美國醫療器械公司總銷售額的 40% 至 50%。
  • 美國的醫院每年在醫療設備生命週期服務成本上花費大約 930 億美元。
  • 設備小型化和納米技術等領域的突破為美國金納米顆粒市場的發展提供了巨大機遇。
  • 此外，電子行業的技術進步和研發活動的快速創新對更新更快的電子產品提出了很高的需求。 在美國，專注於高端產品的製造工廠和開發中心數量激增，預計這將在預測期內提振對金納米粒子的需求。
  • 由於加拿大人重視新產品創新，加拿大消費電子行業在關鍵產品類別中取得了增長並抓住了新機遇。 推動該行業增長的一個因素是該國改善的網絡連接。
  • 因此，由於上述因素，預計該地區的金納米粒子市場在預測期內將呈現高速增長。

金納米顆粒市場競爭者分析

金納米顆粒市場具有部分整合的性質。 所研究市場的主要參與者包括 Merck KGaA、BBI Solutions、Tanaka Holdings、Nanocomposix 和 Cytodiagnostics Inc 等公司。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 調查結果
  • 調查假設
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 司機
    • 擴大納米技術在醫療行業的應用
    • 高端電子領域的需求增加
  • 約束因素
    • 金價波動
    • COVID-19 造成的不利情況
  • 工業價值鏈分析
  • 波特的五力分析
    • 供應商的議價能力
    • 消費者的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度

第 5 章市場細分

  • 申請
    • 成像
    • 靶向給藥
    • 傳感器
    • 體外診斷
    • 調查
    • 催化
    • 其他用途
  • 最終用戶行業
    • 電子產品
    • 醫療保健
    • 化學
    • 其他最終用戶行業
  • 按地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 意大利
      • 法國
      • 其他歐洲地區
    • 世界其他地區
      • 南美洲
      • 中東

第六章競爭格局

  • 併購、合資企業、聯盟、合同
  • 市場份額 (%)**/排名分析
  • 主要參與者的策略
  • 公司簡介
    • Aurion
    • BBI Solutions
    • Cline Scientific AB
    • Cytodiagnostics Inc.
    • Sona Nanotech.
    • Meliorum Technologies Inc.
    • Merck KGaA
    • nanoComposix
    • NanoHybrids
    • NANOPARTZ INC.
    • TANAKA HOLDINGS Co., Ltd.

第七章市場機會與未來趨勢

  • 電子領域的創新
  • 其他商業機會
簡介目錄
Product Code: 64912

The Global Gold Nanoparticles market is expected to witness a CAGR of greater than 10% during the forecast period.

COVID-19 has negatively affected the market studied in receny times. The electronics industry which is a major consumer of gold nanoparticles was severely impacted by t he pandemic. The global electronics shipments have fallen by 3.37 million units in 2020 compared to 2019. Due to the restrictions and the lockdown, many imports and exports were halted for a specified period. Further a lot of projects and plants were paused due to travel restrictions and social distancing protocols. Since the markets are opening, and the lockdowns being lifted in most of the countries, it will be an encouraging sign for the gold nano-particles market in coming years.

Key Highlights

  • Over the mid-term, the major factors driving the market studied are rising nanotechnology applications in the medical industry and rising demand from the high-end electronics sector.
  • On the flipside, volatility in the price of gold is expected to hinder the growth of the market studied.
  • Innovation in the field of electronics is likely to act as an opportunity for the market studied during the forecast period.
  • North America region is expected to dominate the global nanoparticles market; while North America is expected to register the fastest growth through the forecast period.

Gold Nanoparticles Market Trends

Targeted Drug Delivery to Dominate the Market

  • The targeted drug delivery segment represents one of the largest application bases for the gold nanoparticles market.
  • Target drug delivery system is an advanced form of drug delivery system where the medication drug or a pharmacologically active agent is selectively delivered by the nanoparticles at an exact corresponding site of action or absorption, and not to the non-target organs, tissues, or cells.
  • The introduction of nanoparticles to the targeted drug delivery system has resulted in various benefits, such as high therapeutic efficacy, high targeting efficiency, and reproducibility.
  • Gold nanoparticles are used to deliver multiple drug molecules, vaccines, recombinant proteins, or nucleotides into their targets, and can also control the volume of drug released via biological stimuli (internal) or light activation (external).
  • In the United States in the year 2019, the amount spent on medicine was around USD 511 billion increasing by nearly 4% from USD 483.8 billion in 2018. Rising old age population and increasing health risk amongst individuals is only expected to drive the market for targeted drug deliveries and hence gold nanoparticles from this sector.
  • One of the other use of gold nanoparticles is that its surface can be modified using some specialty polymers, like polyethylene glycol (PEG). This is expected to result in increased stability of gold nanoparticles in different physiological conditions and also to provide a multiformity of combinations on gold nanoparticles. This is further expected to boost the usage of gold nanoparticles in treated drug delivery applications.
  • Therefore, all the above mentioned factors are expected to drive the demand for the market studied in coming years.

North America to Dominate the Market

  • North America region is expected to dominate the global gold nanopertocles market during the forecast period.
  • The medical technology of the United States continues to be one of the most vital and dynamic sectors of the region and a leading force in the revolution that is transforming the health care system.
  • The United States is a leading healthcare industry in the world, the expenditure on healthcare in United States accounted to 17% of its national GDP and reached a value of USD 3.8 trillion in 2019, a y-o-y growth of 4.6% from 2018. The growth is expected to continue further through the upcoming years too.
  • The medical technology of the country is one of the best globally and offers state-of-the-art life-saving and life-enhancing products. Fueled by huge research and development investments, the medical technology of the country set a standard on all relevant measures of growth, employment trends, production values, exports, global market share, venture capital financing.
  • Adiitionally, apprximately 35% -40% of the total domestic medical device production is exported, and a similar share of the United States' domestic consumption is imported. Overseas sales account for approximately 40% - 50% of the overall revenues for United States medical device companies, including the foreign subsidiaries' revenue.
  • The American Hospitals Annually spend around USD 93 billion per year on service on the Medical devices lifecycle cost.
  • The breakthroughs in areas, such as device miniaturization and nanotechnology, have created vast opportunities for the growth of the gold nanoparticles market in the United States.
  • Furthermore, owing to the rapid pace of innovation in the advancement of technology and R&D activities in the electronics industry, there is a high demand for newer and faster electronic products. There is a spur in the number of manufacturing plants and development centers in the United States that are focusing on high-end products, which is expected to boost the demand for gold nanoparticles over the forecast period.
  • Canadian consumer electronics industry experienced growth and grabbed new opportunities in the key product category, as Canadians value new product innovations. The factor driving the growth of this industry is the improved network connectivity in the country.
  • Hence, due to the aforementioned factors, the market for gold nanoparticles in the region is expected to witness high growth over the forecast period.

Gold Nanoparticles Market Competitor Analysis

The gold nanoparticles market is partially consolidated in nature. The major companies of the market studied include Merck KGaA, BBI Solutions, Tanaka Holdings Co Ltd., Nanocomposix, and Cytodiagnostics Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Rising Nanotechnology Applications in the Medical Industry
    • 4.1.2 Rising Demand from the High-end Electronics Sector
  • 4.2 Restraints
    • 4.2.1 Volatility in Price of Gold
    • 4.2.2 Unfavorable Conditions Arising due to the Impact of COVID-19
  • 4.3 Industry Value-Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION

  • 5.1 Application
    • 5.1.1 Imaging
    • 5.1.2 Targeted Drug Delivery
    • 5.1.3 Sensors
    • 5.1.4 In Vitro Diagnostics
    • 5.1.5 Probes
    • 5.1.6 Catalysis
    • 5.1.7 Other Applications
  • 5.2 End-user Industry
    • 5.2.1 Electronics
    • 5.2.2 Healthcare
    • 5.2.3 Chemicals
    • 5.2.4 Other End-user Industries
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 Italy
      • 5.3.3.4 France
      • 5.3.3.5 Rest of Europe
    • 5.3.4 Rest of the World
      • 5.3.4.1 South America
      • 5.3.4.2 Middle-East

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share (%)**/ Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Aurion
    • 6.4.2 BBI Solutions
    • 6.4.3 Cline Scientific AB
    • 6.4.4 Cytodiagnostics Inc.
    • 6.4.5 Sona Nanotech.
    • 6.4.6 Meliorum Technologies Inc.
    • 6.4.7 Merck KGaA
    • 6.4.8 nanoComposix
    • 6.4.9 NanoHybrids
    • 6.4.10 NANOPARTZ INC.
    • 6.4.11 TANAKA HOLDINGS Co., Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Innovation in the Field of Electronics
  • 7.2 Other Opportunities